These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36585926)
1. Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity. Su Z; Su H; Xu J; Wei G; Qu L; Ni T; Yang D; Zhu Y Aging (Albany NY); 2022 Dec; 15(1):70-91. PubMed ID: 36585926 [TBL] [Abstract][Full Text] [Related]
2. The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization. Dashti P; van de Peppel J; Thaler R; Paradise CR; Stein GS; Montecino MA; van Leeuwen JPTM; van der Eerden BJ; Dudakovic A; van Wijnen AJ Gene; 2023 Jan; 851():146928. PubMed ID: 36191822 [TBL] [Abstract][Full Text] [Related]
3. Histone methyltransferase Smyd3 is a new regulator for vascular senescence. Yang D; Wei G; Long F; Nie H; Tian X; Qu L; Wang S; Li P; Qiu Y; Wang Y; Hong W; Ni T; Liu X; Zhu YZ Aging Cell; 2020 Sep; 19(9):e13212. PubMed ID: 32779886 [TBL] [Abstract][Full Text] [Related]
5. Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation. Su H; Meng C; Xu J; Su Z; Xiao C; Yang D Cell Death Dis; 2022 Oct; 13(10):890. PubMed ID: 36270984 [TBL] [Abstract][Full Text] [Related]
6. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Abu-Farha M; Lambert JP; Al-Madhoun AS; Elisma F; Skerjanc IS; Figeys D Mol Cell Proteomics; 2008 Mar; 7(3):560-72. PubMed ID: 18065756 [TBL] [Abstract][Full Text] [Related]
7. Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis. Zeng Y; Qiu R; Yang Y; Gao T; Zheng Y; Huang W; Gao J; Zhang K; Liu R; Wang S; Hou Y; Yu W; Leng S; Feng D; Liu W; Zhang X; Wang Y Cell Rep; 2019 Nov; 29(6):1482-1498.e4. PubMed ID: 31693890 [TBL] [Abstract][Full Text] [Related]
8. SMYD2 Drives Mesendodermal Differentiation of Human Embryonic Stem Cells Through Mediating the Transcriptional Activation of Key Mesendodermal Genes. Bai HJ; Zhang P; Ma L; Liang H; Wei G; Yang HT Stem Cells; 2019 Nov; 37(11):1401-1415. PubMed ID: 31348575 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex. Brown MA; Sims RJ; Gottlieb PD; Tucker PW Mol Cancer; 2006 Jun; 5():26. PubMed ID: 16805913 [TBL] [Abstract][Full Text] [Related]
10. SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency. Boehm D; Jeng M; Camus G; Gramatica A; Schwarzer R; Johnson JR; Hull PA; Montano M; Sakane N; Pagans S; Godin R; Deeks SG; Krogan NJ; Greene WC; Ott M Cell Host Microbe; 2017 May; 21(5):569-579.e6. PubMed ID: 28494238 [TBL] [Abstract][Full Text] [Related]
11. Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation. Zhang X; Tanaka K; Yan J; Li J; Peng D; Jiang Y; Yang Z; Barton MC; Wen H; Shi X Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17284-9. PubMed ID: 24101509 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis. Kim K; Ryu TY; Jung E; Han TS; Lee J; Kim SK; Roh YN; Lee MS; Jung CR; Lim JH; Hamamoto R; Lee HW; Hur K; Son MY; Kim DS; Cho HS Exp Mol Med; 2023 May; 55(5):952-964. PubMed ID: 37121971 [TBL] [Abstract][Full Text] [Related]
14. SMYD2-mediated TRAF2 methylation promotes the NF-κB signaling pathways in inflammatory diseases. Wu W; Wang J; Xiao C; Su Z; Su H; Zhong W; Mao J; Liu X; Zhu YZ Clin Transl Med; 2021 Nov; 11(11):e591. PubMed ID: 34841684 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non-Histone Substrates. Weirich S; Schuhmacher MK; Kudithipudi S; Lungu C; Ferguson AD; Jeltsch A Chembiochem; 2020 Jan; 21(1-2):256-264. PubMed ID: 31612581 [TBL] [Abstract][Full Text] [Related]
16. The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) production. Xu G; Liu G; Xiong S; Liu H; Chen X; Zheng B J Biol Chem; 2015 Feb; 290(9):5414-23. PubMed ID: 25583990 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/AKT activation and tumorigenesis of pancreatic adenocarcinoma. Xu Z; Liu Y; Pan Z; Qin L Histol Histopathol; 2024 Feb; 39(2):263-277. PubMed ID: 37232506 [TBL] [Abstract][Full Text] [Related]
18. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease. Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386 [TBL] [Abstract][Full Text] [Related]
19. The ribosomal protein eL21 interacts with the protein lysine methyltransferase SMYD2 and regulates its steady state levels. Khan MIK; Charles RCM; Ramachandran R; Gupta S; Govindaraju G; Mishra R; Rajavelu A; Coumar MS; Chavali S; Dhayalan A Biochim Biophys Acta Mol Cell Res; 2021 Aug; 1868(9):119079. PubMed ID: 34147559 [TBL] [Abstract][Full Text] [Related]
20. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation. Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]